Category: by publisher

Diederik Stapel retraction count hits 50

stapel_npcIt’s Diederik Stapel’s golden retraction: Number 50.

The lucky notice appears in Social Psychology: Continue reading Diederik Stapel retraction count hits 50

Post 982 — in which we find plagiarized bone graft paper that grafted from other papers

thesurgeonThe Surgeon has retracted a 2012 article by a group from the U.K. who took text from a previously published article. So, you say? Nu?

Well, we found — through relatively little effort — that the plagiarizees were themselves, shall we say, liberal in their use of material from other sources.

The retracted article was titled “Bone graft substitutes: What are the options?,” and it appeared in August 2012. One of the options, we guess, was to steal text.

According to the retraction notice: Continue reading Post 982 — in which we find plagiarized bone graft paper that grafted from other papers

Error scuppers paper on treatment for liver fibrosis

pharmbioPharmaceutical Biology has retracted a 2012 paper by a group of liver researchers from China after the discovery of an error that evidently invalidated the results in the paper.

The article, “Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis,” purported to show that

protocatechuic aldehyde, the major degradation of phenolic acids … has potentially conferring antifibrogenic effects.

In other words, the compound appears to prevent the formation of liver fibroids.
But it doesn’t — at least, not according to the study — as the retraction notice explains: Continue reading Error scuppers paper on treatment for liver fibrosis

Flu paper duplication earns Expression of Concern

influenzaA six year-old review on bird flu that failed to credit some content from another six year-old review of bird flu is now stamped with an Expression of Concern.

Here’s the notice, from Influenza and Other Respiratory Viruses: Continue reading Flu paper duplication earns Expression of Concern

The “unintentionality” of being leads to nothingness for paper on protein’s role in cancer

empcoverA group of cancer researchers in Argentina has retracted a paper on the p300 protein in breast cancer that appeared in Experimental and Molecular Pathology.

The article, titled “Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer,” was published in 2010 by Maria E. Fermento and colleagues. It has been cited 11 times since, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice: Continue reading The “unintentionality” of being leads to nothingness for paper on protein’s role in cancer

Toothless wonder? Paper on “oldest human fossil in Europe” temporarily removed from journal’s site

j human evolutionA paper about a high-profile human fossil has been mysteriously removed from the journal that published it just two weeks ago.

Here’s the notice for “The oldest human fossil in Europe dated to ca. 1.4 Ma at Orce (Spain),” originally published on March 5: Continue reading Toothless wonder? Paper on “oldest human fossil in Europe” temporarily removed from journal’s site

“Considerable overlap” leads to retraction of medical imaging paper

PRL cover313

We have poked fun at Pattern Recognition Letters before for failing to catch blatant plagiarism. We probably should have held off on those jokes for this post.

A group of IT researchers from India has suffered the retraction of a paper in PRL for heavily basing the piece on at least four previous papers written by one of the co-authors without proper attribution (not that such attribution likely would have absolved the sin).

The paper, titled “A robust kernelized intuitionistic fuzzy c-means clustering algorithm in segmentation of noisy medical images,” was published in January of this year by Prabhjot Kaur and colleagues.

Here’s the retraction notice:

Continue reading “Considerable overlap” leads to retraction of medical imaging paper

Retraction nine appears for Alirio Melendez

alirio_melendezAn immunologist found by a former employer to have committed misconduct in more than 20 papers has had another paper retracted.

Here’s the notice for “Refining siRNA in vivo transfection: Silencing SPHK1 reveals its key role in C5a-induced inflammation in vivo,” by Alirio Melendez and colleagues in The International Journal of Biochemistry & Cell Biology: Continue reading Retraction nine appears for Alirio Melendez

Paper — with longest title ever? — retracted for lack of author approval

inorgchimactaThe journal Inorganica Chimica Acta has retracted a paper it published earlier this year over an authorship dispute involving the lead researcher and his colleagues in France.

The title of the paper — whose bulk alone gave us a headache  — was “Reaction of a bidentate ligands (4,4′-dimethyl 2,2′-bipyridine) with planar-chiral chloro-bridged ruthenium: Synthesis of cis-dicarbonyl[4,4′-dimethyl-2,2′-bipyridine- κO1,κO2]{2-[tricarbonyl(η6-phenylene- κC1)chromium]pyridine-κN}ruthenium hexafluorophosphate” — and it purportedly came from a lab in Beirut.

However, as the retraction notice indicates, that’s not quite so:

Continue reading Paper — with longest title ever? — retracted for lack of author approval

Duplication, aka self-plagiarism, meets management-speak

management learningWhat happens when people who study management have to write a retraction notice? This, from Management Learning, regarding a paper by Gordon Müller-Seitz of the Free University of Berlin, suggests one possibility: Continue reading Duplication, aka self-plagiarism, meets management-speak